We are live on ! Find out more
GFM

GF Fund Management Portfolio holdings

AUM $5.98B
1-Year Est. Return 80.99%
This Fund
S&P 500
This Quarter Est. Return
+20.94%
1 Year Est. Return
+80.99%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.51B
AUM Growth
+$540M
Cap. Flow
-$18.6M
Cap. Flow %
-0.34%
Top 10 Hldgs %
46.25%
Holding
691
New
31
Increased
112
Reduced
426
Closed
60

Top Buys

Rank Stock Value
1
LITE icon
Lumentum
LITE
+$33.3M
2
BE icon
Bloom Energy
BE
+$30.1M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$25M
4
SNDK
Sandisk
SNDK
+$23.5M
5
NBIS
Nebius Group N.V.
NBIS
+$22.4M

Top Sells

Rank Stock Value
1
BTI icon
British American Tobacco
BTI
+$36.2M
2
CLS icon
Celestica
CLS
+$21.9M
3
WMT icon
Walmart Inc
WMT
+$21.5M
4
UNH icon
UnitedHealth
UNH
+$20.7M
5
YUMC icon
Yum China
YUMC
+$14.8M

Sector Composition

Rank Sector Weight
1 Technology 48.98%
2 Communication Services 15.81%
3 Consumer Discretionary 13.07%
4 Healthcare 6.06%
5 Consumer Staples 4.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TVTX icon
401
Travere Therapeutics
TVTX
$5.33B
$45.8K ﹤0.01%
1,918
-280
-13% -$5.26K
DNLI icon
402
Denali Therapeutics
DNLI
$3.86B
$45.7K ﹤0.01%
3,146
-539
-15% -$7.75K
COIN icon
403
Coinbase
COIN
$43.1B
$45.2K ﹤0.01%
134
-244
-65% -$82.7K
APLE icon
404
Apple Hospitality REIT
APLE
$3.92B
$45.2K ﹤0.01%
3,764
-238
-6% -$2.94K
RXRX icon
405
Recursion Pharmaceuticals
RXRX
$1.61B
$44.9K ﹤0.01%
9,193
-582
-6% -$3.06K
LINE
406
Lineage Inc
LINE
$9.76B
$44.7K ﹤0.01%
+1,157
New +$48.1K
LXP icon
407
LXP Industrial Trust
LXP
$3.58B
$44.2K ﹤0.01%
987
-56
-5% -$2.41K
AKR icon
408
Acadia Realty Trust
AKR
$3.08B
$43.9K ﹤0.01%
2,179
+66
+3% +$1.27K
OCUL icon
409
Ocular Therapeutix
OCUL
$1.85B
$43.8K ﹤0.01%
3,743
-283
-7% -$3.38K
DEI icon
410
Douglas Emmett
DEI
$2.02B
$43.3K ﹤0.01%
2,778
-176
-6% -$2.75K
COGT icon
411
Cogent Biosciences
COGT
$7.07B
$43.2K ﹤0.01%
3,006
+178
+6% +$2.11K
MPT
412
Medical Properties Trust
MPT
$2.81B
$42.9K ﹤0.01%
8,460
-545
-6% -$2.4K
ANIP icon
413
ANI Pharmaceuticals
ANIP
$1.83B
$42.8K ﹤0.01%
467
-71
-13% -$5.79K
UE icon
414
Urban Edge Properties
UE
$2.87B
$42.5K ﹤0.01%
2,077
-141
-6% -$2.81K
FCPT icon
415
Four Corners Property Trust
FCPT
$2.8B
$40.9K ﹤0.01%
1,677
-71
-4% -$1.83K
SRPT icon
416
Sarepta Therapeutics
SRPT
$1.64B
$40.5K ﹤0.01%
2,102
-344
-14% -$6.13K
VERA icon
417
Vera Therapeutics
VERA
$2.37B
$39.9K ﹤0.01%
1,373
-248
-15% -$5.74K
NTLA icon
418
Intellia Therapeutics
NTLA
$1.55B
$39.9K ﹤0.01%
2,310
-298
-11% -$3.67K
APGE icon
419
Apogee Therapeutics
APGE
$10.2B
$39.4K ﹤0.01%
992
-161
-14% -$6.15K
DYN icon
420
Dyne Therapeutics
DYN
$4.8B
$38.7K ﹤0.01%
3,061
+456
+18% +$5.2K
HROW icon
421
Harrow
HROW
$1.45B
$38.4K ﹤0.01%
796
-115
-13% -$4.33K
PK icon
422
Park Hotels & Resorts
PK
$3.03B
$37.1K ﹤0.01%
3,346
-215
-6% -$2.42K
NSA
423
DELISTED
National Storage Affiliates Trust
NSA
$37K ﹤0.01%
1,223
-58
-5% -$1.81K
IVT icon
424
InvenTrust Properties
IVT
$2.74B
$36.9K ﹤0.01%
1,291
-75
-5% -$2.13K
EWTX icon
425
Edgewise Therapeutics
EWTX
$4.42B
$36.8K ﹤0.01%
2,266
-158
-7% -$2.24K
15 16
17
18 19

Similar funds

CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
BP
BC Partners New York $5.96B AUM 15.21% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $5.94B AUM 18.44% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
AL
Appaloosa LP Short Hills, New Jersey $5.93B AUM 44.55% 1-Year Est. Return
CGPCS
Capital Group Private Client Services Los Angeles, California $5.93B AUM 27.73% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

GF Fund Management's Q3 2025 Portfolio in Review

As of Q3 2025, GF Fund Management held 691 positions worth $5.51B, up 11% from $4.97B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

GF Fund Management's Q3 2025 filing shows 31 new, 112 increased, 426 reduced and 60 closed positions. Its largest new stake was Bloom Energy: 648,856 shares worth $54.9M. The largest sale was British American Tobacco, an estimated $36.2M.

By sector, the portfolio is most concentrated in Technology at 49% of assets, up from 46% a quarter earlier, followed by Communication Services and Consumer Discretionary.

  • GF Fund Management's largest Q3 2025 buy was Bloom Energy: 648,856 shares worth $54.9M.
  • GF Fund Management added most to Lumentum in Q3 2025, an estimated $33.3M increase.
  • GF Fund Management's biggest Q3 2025 reduction was British American Tobacco, cutting an estimated $36.2M.
  • GF Fund Management fully exited Yum China in Q3 2025, selling an estimated $14.8M.
  • GF Fund Management's ten largest holdings make up 46% of its $5.51B portfolio in Q3 2025.
  • GF Fund Management opened 31 new positions and closed 60 in Q3 2025.
  • GF Fund Management's portfolio value rose 11% quarter-over-quarter to $5.51B.

Based on GF Fund Management's 13F filing for Q3 2025, filed 7 Nov 2025.